{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:59:19Z","timestamp":1763755159842,"version":"3.45.0"},"reference-count":25,"publisher":"Oncology Nursing Society (ONS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2006,12,1]]},"DOI":"10.1188\/06.cjon.731-736","type":"journal-article","created":{"date-parts":[[2006,12,20]],"date-time":"2006-12-20T12:54:52Z","timestamp":1166619292000},"page":"731-736","source":"Crossref","is-referenced-by-count":1,"title":["Management of Acute Decompensated Heart Failure in Patients With Cancer"],"prefix":"10.1188","volume":"10","author":[{"given":"Catherine C.","family":"Burke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anecita","family":"Fadol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,1,11]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Abraham, W.T., Adams, K.F., Fonarow, G.C., Constanzo, M.R., Berkowitz, R.L., LeJemtel, T.H., et al. (2005). In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). <i>Journal of the American College of Cardiology, 46<\/i>, 57-64.","DOI":"10.1016\/j.jacc.2005.03.051"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Abraham, W.T., Lowes, B.D., Ferguson, D.A., Odom, J., Kim, J.K., Robertson, A.D., et al. (1998). Systemic hemodynamic, neurohormonal, and renal effects of a steady state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. <i>Journal of Cardiac Failure, 4<\/i>, 37-44.","DOI":"10.1016\/S1071-9164(98)90506-1"},{"key":"E00003","unstructured":"American Heart Association. (2003). <i>Heart and stroke statistical update.<\/i> Dallas, TX: Author."},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Burger, A.J. (2005). A review of the renal and neurohormonal effects of B-type natriuretic peptide. <i>Congestive Heart Failure, 11<\/i>, 30-38.","DOI":"10.1111\/j.1527-5299.2005.03794.x"},{"key":"E00005","unstructured":"Burger, A.J., Dennish, G., Horton, D., Koren, M., & Torre, G. (2000). Nesiritide therapy for decompensated CHF is not proarrhythmic. <i>Journal of the American College of Cardiology, 35<\/i>, 172."},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Davie, A.P., Francis, C.M., Caruana, L., Sutherland, G.R., & McMurray, J.J. (1997). The prevalence of left ventricular diastolic filling abnormalities in patients with suspected heart failure. <i>European Heart Journal, 18<\/i>, 981-984.","DOI":"10.1093\/oxfordjournals.eurheartj.a015387"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Dec, G.W. (2005). Acute decompensated heart failure: The shrinking role of inotropic therapy. <i>Journal of the American College of Cardiology, 46<\/i>(T), 65-67.","DOI":"10.1016\/j.jacc.2005.04.007"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"DiDomenico, R.J., Park, H.Y., Southworth, M.R., Eyrich, H.M., Lewis, R.K., Finley, J.M., et al. (2004). Guidelines for acute decompensated heart failure treatment. <i>Annals of Pharmacotherapy, 38<\/i>, 649-660.","DOI":"10.1345\/aph.1D481"},{"key":"E00009","unstructured":"Ewer, M.S., & Benjamin, R.S. (2001). Cardiotoxicity of chemotherapeutic drugs. In M.C. Perry (Ed.), <i>The chemotherapy source book<\/i> (p. 458-467). Philadelphia: Lippincott Williams and Wilkins."},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Fonarow, G.C., & Weber, J.E. (2004). Rapid clinical assessment of hemodynamic profiles and targeted treatment of patients with acutely decompensated heart failure. <i>Clinical Cardiology, 27<\/i>(Suppl. V), V-1-V-9.","DOI":"10.1002\/clc.4960271702"},{"key":"E00011","unstructured":"Francis, G.S., & Tang, W.H. (2003). Pathophysiology of congestive heart failure. <i>Reviews in Cardiovascular Medicine, 4<\/i>(Suppl. 2), S14-S20."},{"key":"E00012","doi-asserted-by":"crossref","unstructured":"Ghalie, R.G., Edan, G., Laurent, M., Mausch, E., Eisenman, S., Hartung, H.P., et al. (2002). Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS. <i>Neurology, 59<\/i>, 909-913.","DOI":"10.1212\/WNL.59.6.909"},{"key":"E00013","unstructured":"Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., et al. (2005). ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines [Electronic version]. <i>Circulation, 112<\/i>, E154-E235."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"Hunt, S.A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldman, A.M., Francis, G.S., et al. (2001). ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. <i>Journal of the American College of Cardiology, 38<\/i>, 2101-2113.","DOI":"10.1016\/S0735-1097(01)01683-7"},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Maeda, K., Tsutamoto, T., Wada, A., Hisanaga, T., & Kinoshita, M. (1998). Plasma brain natriuretic peptide as a biochemical marker of high left ventricular enddiastolic pressure in patients with symptomatic left ventricular dysfunction. <i>American Heart Journal, 135<\/i>(5, Pt. 1), 825-832.","DOI":"10.1016\/S0002-8703(98)70041-9"},{"key":"E00016","doi-asserted-by":"crossref","unstructured":"Maisel, A.S., Krishnaswamy, P., Nowak, R.M., McCord, J., Hollander, J.E., Duc, P., et al. (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. <i>New England Journal of Medicine, 347<\/i>, 161-167.","DOI":"10.1056\/NEJMoa020233"},{"key":"E00017","doi-asserted-by":"crossref","unstructured":"McBride, B.F., & White, C.M. (2003). Acute decompensated heart failure: A contemporary approach to pharmacotherapeutic management. <i>Pharmacotherapy, 23<\/i>, 997-1020.","DOI":"10.1592\/phco.23.8.997.32873"},{"key":"E00018","doi-asserted-by":"crossref","unstructured":"McCullough, P.A., Nowak, R.M., McCord, J., Hollander, J.E., Hermann, H.C., Steg, P.G., et al. (2002). B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from Breathing Not Properly (BNP) Multinational Study. <i>Circulation, 106<\/i>, 416-422.","DOI":"10.1161\/01.CIR.0000025242.79963.4C"},{"key":"E00019","doi-asserted-by":"crossref","unstructured":"Mills, R.M., & Hobbs, R.E. (2001). Drug treatment of patients with decompensated heart failure. <i>American Journal of Cardiovascular Drugs, 1<\/i>, 119-125.","DOI":"10.2165\/00129784-200101020-00005"},{"key":"E00020","doi-asserted-by":"crossref","unstructured":"Nakagawa, O., Ogawa, Y., Itoh, H., Suga, S., Komatsu, Y., Kishimoto, I., et al. (1995). Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: Evidence for brain natriuretic peptide as an \"emergency\" cardiac hormone against ventricular overload. <i>Journal of Clinical Investigation, 96<\/i>, 1280-1287.","DOI":"10.1172\/JCI118162"},{"key":"E00021","doi-asserted-by":"crossref","unstructured":"Peacock, W.F., IV, Emerman, C.L., & Wynn, J. (2004). Early use of nesiritide in the emergency department is associated with improved outcomes: An ADHERE registry analysis [Abstract 256]. <i>Annals of Emergency Medicine, 44<\/i>(Suppl. 4), S78.","DOI":"10.1016\/j.annemergmed.2004.07.258"},{"key":"E00022","doi-asserted-by":"crossref","unstructured":"Silverberg, D.S., Wexler, D., & Iaina, A. (2002). The importance of anemia and its correction in the management of severe congestive heart failure. <i>European Journal of Heart Failure, 4<\/i>, 681-686.","DOI":"10.1016\/S1388-9842(02)00115-0"},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Stevenson, L.W. (1999). Tailored therapy to hemodynamic goals for advanced heart failure. <i>European Journal of Heart Failure, 1<\/i>, 251-257.","DOI":"10.1016\/S1388-9842(99)00015-X"},{"key":"E00024","doi-asserted-by":"crossref","unstructured":"Stevenson, L.W, & Perloff, J.K. (1989). The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. <i>JAMA, 261<\/i>, 884-888.","DOI":"10.1001\/jama.1989.03420060100040"},{"key":"E00025","doi-asserted-by":"crossref","unstructured":"Tsuyuki, R.T., McKelvie, R.S., Arnold, J.M., Avezum, A., Barretto, A.C., Carvalho, A.C., et al. (2001). Acute precipitants of congestive heart failure exacerbations. <i>Archives of Internal Medicine, 161<\/i>, 2337-2342.","DOI":"10.1001\/archinte.161.19.2337"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/W24R61278175066V.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:28Z","timestamp":1763754688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/10\/6\/management-acute-decompensated-heart-failure-patients-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12,1]]}},"alternative-id":["W24R61278175066V"],"URL":"https:\/\/doi.org\/10.1188\/06.cjon.731-736","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}